MentionFox
Home › funding signals › Biostax Corp.
Form D · on the record

Biostax Corp. — Form D filing, June 2026

Biostax Corp. filed a Form D with the Securities and Exchange Commission on 2026-06-08.

Biostax Corp. filed a Form D notice of an exempt securities offering with the SEC on June 8, 2026. Its industry group is Biotechnology. It names Noreen Griffin (Executive Officer) (SEC Form D, June 8, 2026).

125 companies raised this week.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

Andersen Aggregator LLC$1.9BBusiness services
AT Umbrella LLC$1.9BBusiness services
Legora, Inc.$221MAI and software
MD INVESTMENT LLC$169MBusiness services
Serval Inc.$149MAI and software
Check one company free

4 more Biotechnology raises in Florida, June 2026 ↓

Is this your company?

Key facts

Run the free check on Biostax Corp. →

Sell to companies like Biostax Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Biostax Corp.

New Form D on file · 2026-06-08 · the record

$0
raise on the record
D
filing
20
investors in
FLORIDA
based
Open the record →

What the record says

FilingForm D
Filed2026-06-08
Industry groupBiotechnology
Entity typeCorporation
Incorporated inFLORIDA
Year formed2023
BasedWinter Park, FLORIDA
CIK1559356
Accession0001376474-26-000424

Pitching, partnering or investing alongside them? See who really runs and owns Biostax Corp.

Free to see. No signup.

Keep reading

More on the people and the money behind Biostax Corp., from the filings we hold.

More raises like this

Biotechnology raises by companies based in Florida, filed in June 2026, largest first.

What do you want to do with Biostax Corp.?

Get the full cited report on Biostax Corp.

What the filing shows about Biostax Corp.

  • 20 investors had already put money in when it filed.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Biostax Corp.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Who the filing names, and in what role

The filing gives Biostax Corp.'s address as 2431 Aloma Ave, Suite 124, Winter Park, FL 32792.

What the filing says

  • Offered: $7,453,728. Sold: nothing yet. Left to sell: $7,453,728. (filing)
  • Investors: 20 had already invested. (filing)
  • Date of first sale: December 22, 2025. (filing)
  • Types of securities: Equity. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Biostax Corp. See pricing

Is Biostax Corp. a real, registered company?

Biostax Corp. is a registered filer with the SEC (CIK 1559356) and has filed since 2026-06-08. 1 filing is on record, the latest on 2026-06-08.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Biostax Corp.?

Biostax Corp.'s Form D of 2026-06-08 names Noreen Griffin as its officers, directors or promoters.

Biotechnology · by week

Trailing twelve months. 771 filings in Biotechnology, totalled by week.

Want the whole picture on Biostax Corp.?

What the filing shows about Biostax Corp.

  • 20 investors had already put money in when it filed.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Biostax Corp.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Biostax Corp. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Biostax Corp.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

RSS

Tools for this story

Each opens in a new tab, filled in for Biostax Corp.. With no account yet, you sign up free and land on the result.

Cite this page

Permanent URL: https://mentionfox.com/funding/biostax-corp-form-d-26000001
Last updated 2026-10-20
Primary record: SEC filing 1 · SEC filing 2
Biostax Corp. — SEC Form D filing, June 2026. MentionFox, 2026-10-20. https://mentionfox.com/funding/biostax-corp-form-d-26000001